Highlights • Propose the importance of SARS-COV-2 specific antibody detection. • Suggests the importance of complementarity between nucleic acid test and antibody. • Provide a reference for the current diagnosis and treatment of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19), has rapidly spread, resulting in considerable casualties and serious economic loss worldwide. Disease severity and related symptoms markedly vary among individuals. A large number of patients present atypical symptoms, which represent a big challenge for early diagnosis and prompt infection source isolation. Currently, COVID-19 diagnosis predominantly depends on nucleic acid tests (NAT) for SARS-CoV-2 in respiratory specimens, but this method presents a high rate of false negative results. Therefore, serum antibody measurement has been rapidly developed as a supplementary method with the aim of improving diagnostic accuracy. Further, serum antibody levels might help to identify the infection stage, asymptomatic carriers, and patients with diverging severities and to monitor convalescent plasma therapy. In the current review, we aim to present comprehensive evidence to clarify the utility of SARS-CoV-2 antibodies in COVID-19 patients as a reference for use in the clinic.
【저자키워드】 COVID-19, SARS-CoV-2, antibody, Convalescent plasma therapy, Asymptomatic, 【초록키워드】 Treatment, coronavirus disease, coronavirus, severity, Infection, diagnostic, Diagnosis, Symptom, Symptoms, Spread, early diagnosis, Antibody detection, SARS-CoV-2 antibody, Accuracy, nucleic acid test, Patient, COVID-19 diagnosis, Isolation, Asymptomatic carriers, serum antibody, utility, Evidence, respiratory specimens, Atypical, COVID-19 patient, economic loss, acute respiratory syndrome, help, false negative results, MONITOR, responsible, resulting, identify, individuals, 【제목키워드】 serum, SARS-CoV-2 antibody, COVID-19 patient,